Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Quad M Solutions, Inc., an Idaho corporation, (the "Company" or "Registrant"),
is a public holding company (OTC: MMMM) is filing this Current Report on Form
8-K to report that at a meeting of its Board of Directors ("Board") on August
24, 2022, at which meeting all of the members of the Board were present in
person and/or telephonically, the Board unanimously approved the appointment of
Drs. Michael Fonstein, Ph.D. and Yakov Kogan, Ph.D. to the Company's Board.
Dr. Michael Fonstein PhD, age 62, Director: Dr. Michael Fonstein was appointed
as a director of Quad M Solutions, Inc., an Idaho corporation (OTC: MMMM) on
August 24, 2022. In 2021, Dr. Fonstein founded and has served as Chairman and
CEO of BioSynthetic Machines, Inc., an Illinois-based company organized under
the laws of Nevada ("BSMI"). Dr. Fonstein has also founded and served as CEO of
several biotechnology companies including: Integrated Genomics, Inc., Cleveland
Biolabs, Inc., n/k/a Statera Biopharma, Inc. (NASDAQ: STAB), a clinical-stage
biopharmaceutical company developing novel immunotherapies targeting autoimmune,
neutropenia/anemia, emerging viruses and cancers based on a proprietary platform
designed to rebalance the body's immune system and restore homeostasis;
Accelerated Pharma, Inc. and Panacela Labs, Inc., private Delaware companies.
Through his management, several of these companies developed from start-ups to
established and successful ventures, securing multiple rounds of private and
public financing including R&D and service contracts with Fortune 100 companies
and procurement of governmental grants among other funding. Dr. Fonstein has
extensive business and scientific experience and actively involved day-to-day
operations as well as strategic corporate planning of the businesses he founded.
Dr. Fonstein started his career as a research scientist. During his years in
academia, Dr. Fonstein became a recognized expert in microbial genomics and
system biology, founded a genomic center at the University of Chicago, and
published numerous papers in top peer-reviewed scientific journals. Most
recently Dr. Fonstein served as a Computational Scientist at U.S. Department of
Energy's Argonne National Laboratory.
Dr. Yakov Kogan, Ph.D., age 49, Director: Dr. Kogan was appointed as a director
of Quad M Solutions, Inc., an Idaho corporation (OTC: MMMM) on August 24, 2022.
Dr. Kogan co-founder and has served as Chief Business Officer of BSMI from 2021
to the present. Prior to joining BSMI, Dr. Kogan served as a senior consultant
to several private and public biotechnology companies including: serving as a
CEO and director of Cleveland BioLabs, Inc., n/k/a Cytocom, Inc. (NASDAQ: CBLI)
together with Dr. Fonstein, which they had built from its inception to an
operation with over 50 full-time employees, while securing upward of $150
million in equity financing. During his tenure with CBLI, Dr. Kogan played a
significant role in establishing operations, hiring senior operations staff, and
executing the Company's initial public offering on NASDAQ. Prior to CBLI, Dr.
Kogan served as Director for Business Development at Integrated Genomics, a
private company located in Chicago, IL, where he was responsible for commercial
sales and expansion of the company's capital base. Prior to his position as
Director of Business Development, Dr. Kogan worked as a Group Leader/Senior
Scientist at Integrated Genomics as well as at ThermoGen, Inc. In addition, Dr.
Kogan was a Research Associate at the University of Chicago, where he led the
execution of several sophisticated microbial genome sequencing projects.
Dr. Kogan holds a Ph.D. degree in Molecular Biology from VNII Genetica (State
Research Institute of Genetics and Selection of Industrial Microorganisms in
Moscow, Russia), as well as an M.S. degree in Biology from Moscow State
University and an MBA degree from the University of Chicago.
In connection with the appointments of Drs. Fonstein and Kogan, Mr. Douglas
Cole, who served as a Director of Quad M Solutions, Inc., stepped down as a
member of its Board and was appointed as a member of the Company's Advisory
Board. Mr. Cole did not have any disagreements with the operations, policies or
practices of the Company on any matters.
© Edgar Online, source Glimpses